Abstract:Abstract Background Behcet’s disease (BD) is a relapsing systemic vascular autoimmune/inflammatory disease. Despite much effort to investigate BD, there are virtually no unique laboratory markers identified to help in the diagnosis of BD, and the pathogenesis is largely unknown. The aim of this work is to explore interactions between different clinical variables by correlation analysis to determine associations between the functional linkages of different paired variables and potential diagnostic biomarkers of BD. Methods We measured the immunoglobulin proteome (IgG, IgG1–4, IgA, IgA1–2) and 29 clinical variables in 66 healthy controls and 63 patients with BD. We performed a comprehensive clinical variable linkage analysis and defined the physiological, pathological and pharmacological linkages based on the correlations of all variables in healthy controls and BD patients without and with immunomodulatory therapy. We further calculated relative changes between variables derived from comprehensive linkage analysis for better indications in the clinic. The potential indicators were validated in a validation set with 76 patients with BD, 30 healthy controls, 18 patients with Takayasu arteritis and 18 patients with ANCA-associated vasculitis. Results In this study, the variables identified were found to act in synergy rather than alone in BD patients under physiological, pathological and pharmacological conditions. Immunity and inflammation can be suppressed by corticosteroids and immunosuppressants, and integrative analysis of granulocytes, platelets and related variables is likely to provide a more comprehensive understanding of disease activity, thrombotic potential and ultimately potential tissue damage. We determined that total protein/mean corpuscular hemoglobin and total protein/mean corpuscular hemoglobin levels, total protein/mean corpuscular volume, and plateletcrit/monocyte counts were significantly increased in BD compared with controls ( P < 0.05, in both the discovery and validation sets), which helped in distinguishing BD patients from healthy and vasculitis controls. Chronic anemia in BD combined with increased total protein contributed to higher levels of these biomarkers, and the interactions between platelets and monocytes may be linked to vascular involvement. Conclusions All these results demonstrate the utility of our approach in elucidating the pathogenesis and in identifying novel biomarkers for autoimmune diseases in the future.

Plasma and Whole-Blood Chemokine Levels in Patients with Behcet's Disease

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Risk Factors of Cardiovascular Involvement in Patients with Behcet's Disease.

[Serum Levels of Several Chemokines in Patients with Rheumatoid Arthritis].

Salivary and Serum Levels of Both Uric Acid and C-Reactive Protein (CRP) Biomarkers in Patients with Behçet's Disease

Association of high disease activity and serum IL-6 levels with the incidence of inflammatory major organ events in Behçet disease: a prospective registry study

Serum GAS6, sAXL, IL-10, NO, and BCL-2 levels are decreased in patients with Behçet’s disease

Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet’s disease patients receiving immunomodulatory treatment

GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet’s disease

Aberrant monocyte subsets in patients with Behçet's disease

Cytokine Signature Differences in Major Phenotypic Groups of Behçet Disease

Aberrant FcγRIIb and FcγRIII expression on monocytes from patients with Behçet's disease

Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet’s disease

Novel Insights Into Gene Signatures and Their Correlation With Immune Infiltration of Peripheral Blood Mononuclear Cells in Behcet's Disease

Soluble adhesion molecules in Behçet's disease

Characterization of potential salivary biomarkers in Behçet's disease

Transcriptional analysis of neutrophils from patients with Behçet's disease reveals activation and chemotaxis of neutrophils

Treatment with Levamisole and Colchicine Can Result in A Significant Reduction of Il-6, Il-8 or Tnf-Alpha Level in Patients with Mucocutaneous Type of Behcet'S Disease

Circulating Immune Complexome Analysis Identified Anti-Tubulin-Alpha-1c As An Inflammation Associated Autoantibody With Promising Diagnostic Value For Behcet'S Disease

Profile of immunological biomarkers in Behcet's syndrome: a large-scale single-center real-world study

Profile of Immunological Biomarkers in Behcet’s Syndrome: a Large-Scale Single-Center Real-World Study